PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.55%
Revenue growth similar to S's 7.06%. Walter Schloss would see if both companies share industry tailwinds.
8.14%
Gross profit growth 1.25-1.5x S's 7.07%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
60.83%
EBIT growth above 1.5x S's 9.99%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
61.13%
Operating income growth above 1.5x S's 9.94%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
70.37%
Net income growth above 1.5x S's 9.67%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
-110.47%
Negative EPS growth while S is at 12.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-110.47%
Negative diluted EPS growth while S is at 12.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.84%
Share count expansion well above S's 1.41%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.84%
Diluted share count expanding well above S's 1.41%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
49.55%
Similar OCF growth to S's 52.59%. Walter Schloss would assume comparable operations or industry factors.
55.30%
FCF growth above 1.5x S's 29.53%. David Dodd would verify if the firm’s strategic investments yield superior returns.
88.33%
10Y CAGR of 88.33% while S is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
88.33%
5Y CAGR of 88.33% while S is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
35.59%
3Y revenue/share CAGR under 50% of S's 189.08%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
166.35%
Positive long-term OCF/share growth while S is negative. John Neff would see a structural advantage in sustained cash generation.
166.35%
Positive OCF/share growth while S is negative. John Neff might see a comparative advantage in operational cash viability.
154.90%
3Y OCF/share CAGR above 1.5x S's 48.77%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
87.21%
Positive 10Y CAGR while S is negative. John Neff might see a substantial advantage in bottom-line trajectory.
87.21%
Positive 5Y CAGR while S is negative. John Neff might view this as a strong mid-term relative advantage.
97.82%
3Y net income/share CAGR above 1.5x S's 16.94%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
182.87%
Positive growth while S is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
182.87%
Positive 5Y equity/share CAGR while S is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-46.77%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.94%
AR growth well above S's 43.38%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.16%
Inventory is declining while S stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
8.61%
Asset growth above 1.5x S's 1.67%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.12%
BV/share growth above 1.5x S's 0.40%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.60%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-4.82%
Our R&D shrinks while S invests at 5.92%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.35%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.